Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jitka Fucikova

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Journal for Immunotherapy of Cancer|October 14, 2021
Immunological configuration of ovarian carcinoma: features and impact on disease outcomeJitka Fucikova, An Coosemans, Sandra Orsulic, et al.
Cancer Research|May 24, 2011
Human tumor cells killed by anthracyclines induce a tumor-specific immune responseJitka Fucikova, Petra Kralikova, Anna Fialova, et al.
Immunological Reviews|September 5, 2023
Type I interferon and cancerPeter Holicek, Emma Guilbaud, Vanessa Klapp, et al.
Methods in Enzymology|February 1, 2020
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell deathLenka Kasikova, Iva Truxova, Isabelle Cremer, et al.
Oncoimmunology|November 5, 2020
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockadeKarsten A Pilones, Michal Hensler, Camille Daviaud, et al.
Methods in Enzymology|February 1, 2020
Methods to assess DC-dependent priming of T cell responses by dying cellsAnne-Marie Chalupova, Sarka Vosahlikova, Daniela Rozkova, et al.
Oncoimmunology|December 8, 2018
Trial watch: Peptide-based vaccines in anticancer therapyLucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
Oncoimmunology|December 8, 2018
Trial Watch: Toll-like receptor agonists in cancer immunotherapyMelody Smith, Elena García-Martínez, Michael R Pitter, et al.
Cell Death & Disease|November 27, 2020
Detection of immunogenic cell death and its relevance for cancer therapyJitka Fucikova, Oliver Kepp, Lenka Kasikova, et al.
Frontiers in Immunology|June 18, 2015
Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death"Lucillia Bezu, Ligia C Gomes-da-Silva, Heleen Dewitte, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|October 14, 2021
Immunological configuration of ovarian carcinoma: features and impact on disease outcomeJitka Fucikova, An Coosemans, Sandra Orsulic, et al.
Cancer Research|May 24, 2011
Human tumor cells killed by anthracyclines induce a tumor-specific immune responseJitka Fucikova, Petra Kralikova, Anna Fialova, et al.
Immunological Reviews|September 5, 2023
Type I interferon and cancerPeter Holicek, Emma Guilbaud, Vanessa Klapp, et al.
Methods in Enzymology|February 1, 2020
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell deathLenka Kasikova, Iva Truxova, Isabelle Cremer, et al.
Oncoimmunology|November 5, 2020
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockadeKarsten A Pilones, Michal Hensler, Camille Daviaud, et al.
Methods in Enzymology|February 1, 2020
Methods to assess DC-dependent priming of T cell responses by dying cellsAnne-Marie Chalupova, Sarka Vosahlikova, Daniela Rozkova, et al.
Oncoimmunology|December 8, 2018
Trial watch: Peptide-based vaccines in anticancer therapyLucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
Oncoimmunology|December 8, 2018
Trial Watch: Toll-like receptor agonists in cancer immunotherapyMelody Smith, Elena García-Martínez, Michael R Pitter, et al.
Cell Death & Disease|November 27, 2020
Detection of immunogenic cell death and its relevance for cancer therapyJitka Fucikova, Oliver Kepp, Lenka Kasikova, et al.
Frontiers in Immunology|June 18, 2015
Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death"Lucillia Bezu, Ligia C Gomes-da-Silva, Heleen Dewitte, et al.
Pageof 7